First Time Loading...

West Pharmaceutical Services Inc
NYSE:WST

Watchlist Manager
West Pharmaceutical Services Inc Logo
West Pharmaceutical Services Inc
NYSE:WST
Watchlist
Price: 358.72 USD 0.1% Market Closed
Updated: Mar 2, 2024

Intrinsic Value

West Pharmaceutical Services, Inc. manufactures and markets pharmaceuticals, biologics, vaccines and consumer healthcare products. [ Read More ]

The intrinsic value of one WST stock under the Base Case scenario is 248.05 USD. Compared to the current market price of 358.72 USD, West Pharmaceutical Services Inc is Overvalued by 31%.

Key Points:
WST Intrinsic Value
Base Case
248.05 USD
Overvaluation 31%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
West Pharmaceutical Services Inc

Backtest WST Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling WST stocks based on their intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Settings
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?

Fundamental Analysis

Mixed Outlook Amidst Strong Base Growth
2023-Q4 Earnings Call

Mixed Outlook Amidst Strong Base Growth

In 2023, West Pharmaceutical offset a $320 million decline in COVID-19-related sales with robust organic growth in the mid-teens, excluding pandemic effects. For 2024, challenges are expected, with anticipated organic sales growth lowered to 2-3%, a 5-6% decrease from previous estimates. This adjustment is due to continued COVID-19 sales decline, delayed high-value product (HVP) device capacity, customer upgrades, and industry-wide destocking, expected to cause a 2-3% headwind. However, the second half of 2024 is projected to align with long-term growth targets, supported by a robust order book, increased drug production from customers, and improved HVP device capacity from process modifications. HVP devices had double-digit growth in 2023, now 10% of sales, with capacity expansions planned to fully come online by 2025.

Financials

Balance Sheet Decomposition
West Pharmaceutical Services Inc

Current Assets 1.9B
Cash & Short-Term Investments 853.9m
Receivables 512m
Other Current Assets 570.5m
Non-Current Assets 1.9B
Long-Term Investments 210m
PP&E 1.5B
Intangibles 123.6m
Other Non-Current Assets 47m
Current Liabilities 671.8m
Accounts Payable 242.4m
Accrued Liabilities 123.6m
Other Current Liabilities 305.8m
Non-Current Liabilities 276.7m
Long-Term Debt 72.8m
Other Non-Current Liabilities 203.9m
Efficiency
Fundamental Scores

WST Profitability Score
Profitability Due Diligence

West Pharmaceutical Services Inc's profitability score is 66/100. The higher the profitability score, the more profitable the company is.

Exceptional 3-Year Average ROE
Positive 3-Year Average ROIC
Positive Gross Profit
Positive Free Cash Flow
66/100
Profitability
Score

West Pharmaceutical Services Inc's profitability score is 66/100. The higher the profitability score, the more profitable the company is.

WST Solvency Score
Solvency Due Diligence

West Pharmaceutical Services Inc's solvency score is 97/100. The higher the solvency score, the more solvent the company is.

High Interest Coverage
High Altman Z-Score
Long-Term Solvency
Negative Net Debt
97/100
Solvency
Score

West Pharmaceutical Services Inc's solvency score is 97/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

WST Price Targets Summary
West Pharmaceutical Services Inc

Wall Street analysts forecast WST stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for WST is 408.44 USD with a low forecast of 358.55 USD and a high forecast of 493.5 USD.

Lowest
Price Target
358.55 USD
0% Downside
Average
Price Target
408.44 USD
14% Upside
Highest
Price Target
493.5 USD
38% Upside
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Ownership

WST Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

Shareholder Return

WST Price
West Pharmaceutical Services Inc

1M 1M
-6%
6M 6M
-11%
1Y 1Y
+11%
3Y 3Y
+30%
5Y 5Y
+246%
10Y 10Y
+735%
Annual Price Range
358.72
52w Low
314.39
52w High
413
Price Metrics
Average Annual Return 35.78%
Standard Deviation of Annual Returns 58.4%
Max Drawdown -56%
Shares Statistics
Market Capitalization 26.4B USD
Shares Outstanding 73 299 296
Percentage of Shares Shorted 2.06%

WST Return Decomposition
Main factors of price return

What is price return decomposition?

WST News

Other Videos

Company Profile

West Pharmaceutical Services Inc Logo
West Pharmaceutical Services Inc

Country

United States of America

Industry

Life Sciences Tools & Services

Market Cap

26.4B USD

Dividend Yield

0.22%

Description

West Pharmaceutical Services, Inc. manufactures and markets pharmaceuticals, biologics, vaccines and consumer healthcare products. The company is headquartered in Exton, Pennsylvania and currently employs 10,065 full-time employees. The firm operates through two segments: Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers proprietary packaging, containment, and drug delivery products, along with analytical lab services and other integrated services and solutions, primarily to biologic, generic and pharmaceutical drug customers. The Contract-Manufactured Products segment serves as a fully integrated business, focused on the design, manufacture, and automated assembly of complex devices, primarily for pharmaceutical, diagnostic, and medical device customers. This segment manufactures customer-owned components and devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products.

Contact

PENNSYLVANIA
Exton
530 Herman O West Dr
+16105942900.0
https://www.westpharma.com/

IPO

1923-07-27

Employees

10 065

Officers

Chair, President & CEO
Mr. Eric M. Green
Senior VP and Chief Financial & Operations Officer
Mr. Bernard J. Birkett
Senior VP & CTO
Mr. Silji Abraham
Senior VP, General Counsel & Company Secretary
Ms. Kimberly Banks MacKay
Senior VP & Chief Commercial Officer
Ms. Cindy Reiss-Clark
VP, Chief Accounting Officer & Corporate Controller
Mr. Chad R. Winters
Show More
Vice President of Strategy & Investor Relations
Dr. Quintin J. Lai C.F.A., Ph.D.
Vice President of Global Communications
Michele Polinsky
Senior VP of Strategy & Corporate Development
Mr. Rudy Poussot
Chief Human Resources Officer & Senior VP
Ms. Annette F. Favorite
Show Less

See Also

Discover More
What is the Intrinsic Value of one WST stock?

The intrinsic value of one WST stock under the Base Case scenario is 248.05 USD.

Is WST stock undervalued or overvalued?

Compared to the current market price of 358.72 USD, West Pharmaceutical Services Inc is Overvalued by 31%.